TrovaGene

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch TrovaGene and buy or sell other stocks, options, and ETFs commission-free!

About TROV

Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. 

CEO
Mark Erlander, PhD
CEOMark Erlander, PhD
Employees
32
Employees32
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
1999
Founded1999
Employees
32
Employees32

TROV Key Statistics

Market cap
53.17M
Market cap53.17M
Price-Earnings ratio
-4.69
Price-Earnings ratio-4.69
Dividend yield
—
Dividend yield—
Average volume
898.49K
Average volume898.49K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$6.42
52 Week high$6.42
52 Week low
$0.94
52 Week low$0.94
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.